211 related articles for article (PubMed ID: 24448160)
1. Gene therapy using a liver-targeted AAV vector restores nucleoside and nucleotide homeostasis in a murine model of MNGIE.
Torres-Torronteras J; Viscomi C; Cabrera-Pérez R; Cámara Y; Di Meo I; Barquinero J; Auricchio A; Pizzorno G; Hirano M; Zeviani M; Martí R
Mol Ther; 2014 May; 22(5):901-7. PubMed ID: 24448160
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Restoration of Thymidine Phosphorylase Function and Nucleoside Homeostasis Using Hematopoietic Gene Therapy in a Murine Model of Mitochondrial Neurogastrointestinal Encephalomyopathy.
Torres-Torronteras J; Cabrera-Pérez R; Barba I; Costa C; de Luna N; Andreu AL; Barquinero J; Hirano M; Cámara Y; Martí R
Hum Gene Ther; 2016 Sep; 27(9):656-67. PubMed ID: 27004974
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of adeno-associated virus gene therapy in a MNGIE murine model enhanced by chronic exposure to nucleosides.
Vila-Julià F; Cabrera-Pérez R; Cámara Y; Molina-Berenguer M; Lope-Piedrafita S; Hirano M; Mingozzi F; Torres-Torronteras J; Martí R
EBioMedicine; 2020 Dec; 62():103133. PubMed ID: 33232869
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Sustained Effect of Liver-Targeted Adeno-Associated Virus Gene Therapy for Mitochondrial Neurogastrointestinal Encephalomyopathy.
Torres-Torronteras J; Cabrera-Pérez R; Vila-Julià F; Viscomi C; Cámara Y; Hirano M; Zeviani M; Martí R
Hum Gene Ther; 2018 Jun; 29(6):708-718. PubMed ID: 29284302
[TBL] [Abstract][Full Text] [Related]
5. Alpha-1-Antitrypsin Promoter Improves the Efficacy of an Adeno-Associated Virus Vector for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy.
Cabrera-Pérez R; Vila-Julià F; Hirano M; Mingozzi F; Torres-Torronteras J; Martí R
Hum Gene Ther; 2019 Aug; 30(8):985-998. PubMed ID: 30900470
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal dysfunction and overload of nucleosides in thymidine phosphorylase deficiency of MNGIE.
Du J; Liu F; Liu X; Zhao D; Wang D; Sun H; Yan C; Zhao Y
J Transl Med; 2024 May; 22(1):449. PubMed ID: 38741129
[TBL] [Abstract][Full Text] [Related]
7. Thymidine phosphorylase is both a therapeutic and a suicide gene in a murine model of mitochondrial neurogastrointestinal encephalomyopathy.
López-Estévez S; Ferrer G; Torres-Torronteras J; Mansilla MJ; Casacuberta-Serra S; Martorell L; Hirano M; Martí R; Barquinero J
Gene Ther; 2014 Jul; 21(7):673-81. PubMed ID: 24807807
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): case report with a new mutation.
Bariş Z; Eminoğlu T; Dalgiç B; Tümer L; Hasanoğlu A
Eur J Pediatr; 2010 Nov; 169(11):1375-8. PubMed ID: 20585803
[TBL] [Abstract][Full Text] [Related]
9. Transient clinical improvement of a mitochondrial neurogastrointestinal encephalomyopathy-like syndrome after allogeneic haematopoietic stem cell transplantation.
Baker MK; Schutte CM; Ranchhod N; Brittain D; van Rensburg JE
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28765176
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE.
Torres-Torronteras J; Gómez A; Eixarch H; Palenzuela L; Pizzorno G; Hirano M; Andreu AL; Barquinero J; Martí R
Gene Ther; 2011 Aug; 18(8):795-806. PubMed ID: 21451581
[TBL] [Abstract][Full Text] [Related]
11. Deoxynucleoside stress exacerbates the phenotype of a mouse model of mitochondrial neurogastrointestinal encephalopathy.
Garcia-Diaz B; Garone C; Barca E; Mojahed H; Gutierrez P; Pizzorno G; Tanji K; Arias-Mendoza F; Quinzii CM; Hirano M
Brain; 2014 May; 137(Pt 5):1337-49. PubMed ID: 24727567
[TBL] [Abstract][Full Text] [Related]
12. A novel thymidine phosphorylase mutation in a Chinese MNGIE patient.
Wang HF; Wang J; Wang YL; Fan JJ; Mo GL; Gong FY; Chai ZM; Zhang J; Meng HX; Li CX; Guo JH; Pu CQ
Acta Neurol Belg; 2017 Mar; 117(1):259-267. PubMed ID: 27709505
[TBL] [Abstract][Full Text] [Related]
13. Thymidine phosphorylase gene mutations in patients with mitochondrial neurogastrointestinal encephalomyopathy syndrome.
Slama A; Lacroix C; Plante-Bordeneuve V; Lombès A; Conti M; Reimund JM; Auxenfants E; Crenn P; Laforêt P; Joannard A; Seguy D; Pillant H; Joly P; Haut S; Messing B; Said G; Legrand A; Guiochon-Mantel A
Mol Genet Metab; 2005 Apr; 84(4):326-31. PubMed ID: 15781193
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations.
Nishino I; Spinazzola A; Papadimitriou A; Hammans S; Steiner I; Hahn CD; Connolly AM; Verloes A; Guimarães J; Maillard I; Hamano H; Donati MA; Semrad CE; Russell JA; Andreu AL; Hadjigeorgiou GM; Vu TH; Tadesse S; Nygaard TG; Nonaka I; Hirano I; Bonilla E; Rowland LP; DiMauro S; Hirano M
Ann Neurol; 2000 Jun; 47(6):792-800. PubMed ID: 10852545
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial neurogastrointestinal encephalomyopathy: novel pathogenic mutations in thymidine phosphorylase gene in two Italian brothers.
Libernini L; Lupis C; Mastrangelo M; Carrozzo R; Santorelli FM; Inghilleri M; Leuzzi V
Neuropediatrics; 2012 Aug; 43(4):201-8. PubMed ID: 22618301
[TBL] [Abstract][Full Text] [Related]
16. Thymidine phosphorylase mutations cause instability of mitochondrial DNA.
Hirano M; Lagier-Tourenne C; Valentino ML; Martí R; Nishigaki Y
Gene; 2005 Jul; 354():152-6. PubMed ID: 15975738
[TBL] [Abstract][Full Text] [Related]
17. Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome.
Bakker JA; Schlesser P; Smeets HJ; Francois B; Bierau J
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3(Suppl 3):S139-43. PubMed ID: 20151198
[TBL] [Abstract][Full Text] [Related]
18. Hemodialysis in MNGIE transiently reduces serum and urine levels of thymidine and deoxyuridine, but not CSF levels and neurological function.
Röeben B; Marquetand J; Bender B; Billing H; Haack TB; Sanchez-Albisua I; Schöls L; Blom HJ; Synofzik M
Orphanet J Rare Dis; 2017 Aug; 12(1):135. PubMed ID: 28764801
[TBL] [Abstract][Full Text] [Related]
19. Administration of deoxyribonucleosides or inhibition of their catabolism as a pharmacological approach for mitochondrial DNA depletion syndrome.
Cámara Y; González-Vioque E; Scarpelli M; Torres-Torronteras J; Caballero A; Hirano M; Martí R
Hum Mol Genet; 2014 May; 23(9):2459-67. PubMed ID: 24362886
[TBL] [Abstract][Full Text] [Related]
20. Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy.
Garone C; Tadesse S; Hirano M
Brain; 2011 Nov; 134(Pt 11):3326-32. PubMed ID: 21933806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
